Morgan Stanley Stealth Bio Therapeutics Corp Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.18 - $0.71 $900 - $3,550
-5,000 Closed
0 $0
Q1 2022

Oct 27, 2022
BUY
$0.49 - $0.9 $2,450 - $4,500
5,000 New
5,000 $4,000
Q4 2021

Feb 14, 2022
SELL
$0.76 - $1.48 $760 - $1,480
-1,000 Reduced 16.67%
5,000 $4,000
Q3 2021

Nov 15, 2021
BUY
$1.17 - $1.58 $7,020 - $9,480
6,000 New
6,000 $8,000

Others Institutions Holding MITO

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About Stealth BioTherapeutics Corp

MITO Quotes by TradingView
  • Ticker MITO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,548,600
  • Description
  • Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...
More about MITO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email